Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


SYNDAX PHARMACEUTICALS, INC.

SYNDAX PHARMACEUTICALS, INC. Patent applications
Patent application numberTitlePublished
20100305167Administration of an Inhibitor of HDAC - Methods of treating patients with SNDX-275 are provided.12-02-2010
20100298270Novel Compounds and Methods of Using Them - Described herein are novel HDAC modulators, formulations containing them and methods of using them. In some embodiments, the HDAC modulators possess specific stereo chemistry. In other embodiments, the compounds described herein are used in the treatment or prevention of histone deacetylase mediated disorders.11-25-2010
20100267779Novel Compounds and Methods of Using Them - Described herein are novel HDAC inhibitors, formulations containing them and methods of using them. In some embodiments, the HDAC inhibitors possess specific stereochemistry. In other embodiments, the compounds described herein are used in the treatment or prevention of histone deacetylase mediated disorders.10-21-2010
20090149511Administration of an Inhibitor of HDAC and an mTOR Inhibitor - Methods of treating patients with an HDAC inhibitor and an mTOR inhibitor are provided.06-11-2009

Patent applications by SYNDAX PHARMACEUTICALS, INC.